Latest news
ViiV's two-drug Dovato matches three-drug Biktarvy in first head-to-head HIV trial - AllSciAllSci · Tue, 28 Jul 2026 08:24:47 GMTDovato Shows Noninferior Efficacy to Biktarvy in Head-to-Head HIV Trial - Contagion LiveContagion Live · Mon, 27 Jul 2026 21:05:34 GMTHead-to-head study shows Dovato as effective as Biktarvy in HIV | AIDS 2026 - Managed Healthcare ExecutiveManaged Healthcare Executive · Mon, 27 Jul 2026 07:00:00 GMTViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV - Business WireBusiness Wire · Mon, 27 Jul 2026 07:00:00 GMT